×

Valeant's worst day ever

12:00 PM ET Tue, 15 March 2016

Shares of Valeant Pharmaceuticals are plunging after fourth quarter earnings and reducing its first-quarter and full-year outlook. CNBC's Meg Tirrell provides insight.